Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

H Saito; Y Tani; A Ozaki; T Sawano; Y Shimada; K Yamamoto; T Tanimoto

doi:10.1016/j.cmi.2019.07.025

Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

Clin Microbiol Infect. 2019 Nov;25(11):1304-1306. doi: 10.1016/j.cmi.2019.07.025. Epub 2019 Aug 8.

Authors

H Saito¹, Y Tani², A Ozaki³, T Sawano⁴, Y Shimada⁵, K Yamamoto², T Tanimoto²

Affiliations

¹ Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan. Electronic address: h.saito0515@gmail.com.
² Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
³ Medical Governance Research Institute, Minato-ku, Tokyo, Japan; Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
⁴ Department of Surgery, Minamisoma Municipal General Hospital, Minamisoma, Fukushima, Japan.
⁵ Department of Neurosurgery, Minamisoma Municipal General Hospital, Minamisoma, Fukushima, Japan.

PMID: 31401175
DOI: 10.1016/j.cmi.2019.07.025

No abstract available

Keywords: Clinical practice guidelines; Financial conflicts of interest; Methicillin-resistant Staphylococcus aureus guidelines; Payments database; Transparency.

MeSH terms

Anti-Bacterial Agents / economics
Anti-Bacterial Agents / therapeutic use
Authorship*
Conflict of Interest / economics
Disclosure / ethics
Drug Industry / economics*
Drug Industry / ethics*
Financial Support / ethics*
Humans
Japan
Methicillin-Resistant Staphylococcus aureus / drug effects
Practice Guidelines as Topic*
Practice Patterns, Physicians' / economics
Practice Patterns, Physicians' / ethics
Staphylococcal Infections / drug therapy

Substances

Anti-Bacterial Agents